405 online
Most Popular Choices
Share on Facebook 27 Printer Friendly Page More Sharing
OpEdNews Op Eds   


By       (Page 1 of 1 pages)   3 comments

Just how do the sales team work at GlaxoSmithKline?

In 1998 GlaxoSmithKline issued a marketing strategy paper called 'Toward the Second Billion'. It suggested that people with common phobias could be persuaded to take Seroxat.

It raised concerns with Mental Health campaigners about how Pharmaceutical Companies market drugs and influence medical research.

In a clever multi-million pound spin phobias were renamed 'social anxiety disorders' thus enabling Seroxat to be prescribed for a whole host of symptoms. Basically, anyone that was low on self-esteem (confidence) were targeted. Symptoms such as:

Fear that everyone's attention is focused on them
Fear that they will make mistakes and everyone will notice
Feeling that everyone else is more capable in the same situation
Fear that they are being judged by others
Fear that they will embarrass or humiliate themselves in front of others

Fears that have been around since man learned to communicate and now, it seemed, ones that could be brushed aside by swallowing GSK's wonder drug, Seroxat.

Do we blame the GP's for handing out these drugs like sweets, do we blame the MHRA for allowing this manipulative marketing to be processed or do we blame GlaxoSmithKline for inventing disease purely to keep Seroxat on top of the table?

The signs were abundantly clear from very early on that GlaxoSmithKline's money making drug, Seroxat, was being forced upon doctor's - in turn being forced upon the patient who was feeling down. The MHRA did what they did best - they just sat back and rubbed thier hands at the funding they would recieve from the likes of GlaxoSmithKline, hardly surprising with two ex-employees of GlaxoSmithKline now sitting on the agency at MHRA HQ, also hardly surprising that GlaxoSmithKline's spin doctor, Alistair Benbow, should robustly deny any problems with Seroxat when interviewed by the media. Alistair Breckenridge, of the MHRA, would also go on record promoting the use of Seroxat.

The reason why my Seroxat Sufferers blog (http://fiddaman.blogspot.com) was created was to raise public awareness, as you can see by the 28,000+ hits I am achieving that. Blogs such as Seroxat Secrets, GSK Licence to Kill and websites that offer support such as Paxil Progress and a number of Yahoo groups have also stood up to voice their concerns. Attempts made by MP's to voice their concerns have been quoshed by GlaxoSmithKline with threatening letters - Paul Flynn, MP for Newport, tabled the following Early Day Motion earlier this year:

EDM 767
Flynn, Paul

That this House questions the propriety and courtesy of the action of GlaxoSmithKline (GSK) in writing to hon. Members with constituency interests in GSK urging them to oppose Motions for Early Day (EDMs) critical of their conduct, then denying originators of the EDMs details of the content of their messages when requested.

GlaxoSmithKline can threaten MP's but they cannot threaten the common man who has nothing to lose, one that has lost pretty much everything already because of the drug they manufactured and continue to tout as a safe drug.

There are many Pharmaceutical Companies who visit the Seroxat Sufferers blog, no doubt gloating at the bad press GlaxoSmithKline are getting, to be honest they are all as bad as one another as they all put money at the top of their agendas - disregarding human life.

Collectively, blogs such as mine and a whole host of others can make a change and their authors can sleep soundly at night in the knowledge that GlaxoSmithKline will one day NOT be able to throw money at lawsuits. They will eventually come across individuals who refuse to take the money and run. That day is fast approaching

Rate It | View Ratings

ROBERT FIDDAMAN Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

Robert Fiddaman is the author of the book, 'The evidence, however, is clear...the Seroxat scandal'. He has been writing about the pharmaceutical industry and medicine regulators for 7 years. His blog, Seroxat Sufferers, has become popular amongst (more...)
Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Writers Guidelines

Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEd News Newsletter
   (Opens new browser window)

Most Popular Articles by this Author:     (View All Most Popular Articles by this Author)

A Chemical Imbalance - The Serotonin Myth

Billion Dollar Drug Company Law Firm Restructures Connecticut Welfare System

Psychiatric Medication or Play Therapy?

Who Killed Japanese Culture?

Glaxo, Myodil and The UK Regulator

Paxil Study 329 All Over Again?

To View Comments or Join the Conversation:

Tell A Friend